Intra-Cellular Therapies
(NASDAQ:ITCI)
$69.72
0[0.00%]
At close: Mar 27
$69.72
0[0.00%]
PreMarket: 4:00PM EDT
50%
Overview Rating
Speculative
Technicals Analysis
100
0100
Financials Analysis
20
0100
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
3
Nov 23
2
Dec 23
3
1
Jan
5
Feb
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.2
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Intra-Cellular Therapies Inc
Sector
Health Care
Industry
Pharmaceuticals
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating d...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
ITCI
NVO

FAQ

Q

How do I buy Intra-Cellular Therapies (ITCI) stock?

A

You can purchase shares of Intra-Cellular Therapies (NASDAQ: ITCI) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Intra-Cellular Therapies's (ITCI) competitors?

A

Other companies in Intra-Cellular Therapies’s space includes: Novo Nordisk (NYSE:NVO), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Novartis (NYSE:NVS) and Pfizer (NYSE:PFE).

Q

What is the target price for Intra-Cellular Therapies (ITCI) stock?

A

The latest price target for Intra-Cellular Therapies (NASDAQ: ITCI) was reported by Cantor Fitzgerald on Friday, February 23, 2024. The analyst firm set a price target for 101.00 expecting ITCI to rise to within 12 months (a possible 44.87% upside). 36 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Intra-Cellular Therapies (ITCI)?

A

The stock price for Intra-Cellular Therapies (NASDAQ: ITCI) is $69.72 last updated March 27, 2024 at 4:00 PM EDT.

Q

Does Intra-Cellular Therapies (ITCI) pay a dividend?

A

There are no upcoming dividends for Intra-Cellular Therapies.

Q

When is Intra-Cellular Therapies (NASDAQ:ITCI) reporting earnings?

A

Intra-Cellular Therapies’s Q1 earnings are confirmed for Thursday, May 2, 2024.

Q

Is Intra-Cellular Therapies (ITCI) going to split?

A

There is no upcoming split for Intra-Cellular Therapies.

Q

What sector and industry does Intra-Cellular Therapies (ITCI) operate in?

A

Intra-Cellular Therapies is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch